Search results (21)
« Back to PublicationsMenin maintains enhancer-promoter interactions in a leukemia-specific manner
Preprint
Sharlandjieva V. et al, (2026)
A cytoplasmic motif in HLA-E that drives clathrin-mediated endocytosis and VCP-associated postendocytic trafficking.
Journal article
He W. et al, (2025), Proc Natl Acad Sci U S A, 122
Tracking E2-specific substrates.
Journal article
Jones HBL. et al, (2025), Nat Chem Biol, 21, 976 - 977
Integrative proximal-ubiquitomics profiling for deubiquitinase substrate discovery applied to USP30.
Journal article
Damianou A. et al, (2025), Cell Chem Biol, 32, 736 - 751.e8
Protocol to profile spatially resolved NLRP3 inflammasome complexes using APEX2-based proximity labeling.
Journal article
Liang Z. et al, (2024), STAR Protoc, 5
Deubiquitinases in muscle physiology and disorders.
Journal article
Olie CS. et al, (2024), Biochem Soc Trans, 52, 1085 - 1098
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia.
Journal article
Liang Z. et al, (2024), Cell Rep, 43
Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex.
Journal article
Damianou A. et al, (2024), Life Sci Alliance, 7
Proximity proteomics reveals UCH-L1 as an NLRP3 interactor that modulates IL-1β production in human macrophages and microglia
Preprint
Liang Z. et al, (2023)
USP18 is an essential regulator of muscle cell differentiation and maturation.
Journal article
Olie CS. et al, (2023), Cell Death Dis, 14
USP18 is an essential regulator of muscle cell differentiation and maturation
Preprint
Olie CS. et al, (2022)
Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
Journal article
Munnur D. et al, (2021), Nat Immunol, 22, 1416 - 1427
USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
Journal article
Ruiz EJ. et al, (2021), Elife, 10
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities.
Journal article
Liang Z. et al, (2021), Cell Commun Signal, 19
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
Journal article
Pinto-Fernandez A. et al, (2021), Br J Cancer, 124, 817 - 830
